TD Newcrest Downgrades MDS, Inc. (MDZ) to Reduce
More News related to MDZ
- MDS (MDZ) and Danaher Corp. (DHR) Announce Receipt of Second Request from U.S. FTC for MDS Analytical Tech Sale
- MDS Inc. and Danaher Corporation Receive Second Request for Information from U.S. Federal Trade Commission for MDS Analytical Technologies Sale
- MDS Inc. Completes Divestiture of Central Labs Operations
- MDS Inc. Announces Shareholder Approval of Sale of MDS Analytical Technologies
- Jefferies & Co Downgrades MDS Inc. (MDZ) to Hold; Valuation Call
More News related to Downgrades
- Keefe, Bruyette & Woods Downgrades First State Bancorporation (FSNM) to Market Perform
- Keefe, Bruyette & Woods Downgrades R&G Financial (RGFC) to Market Perform
TD Newcrest downgrades MDS, Inc. (NYSE: MDZ) to Reduce.
To see more analyst ratings on MDZ Click Here.
MDS, Inc., a life sciences company, provides products and services for the development of drugs, and the diagnosis and treatment of diseases.
Related Categories
DowngradesStocks Mentioned
+0.08Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
